BioOra and Octane Expand CAR-T Manufacturing Globally
WELLINGTON, New Zealand & KINGSTON, Canada, April 7, 2026 BioOra Limited and Octane Biotech Inc. announced a strategic Letter...
Immunotherapy
Advertisement
Singlomics Doses First Patient in DXP-106 Trial
BEIJING, China, April 7, 2026 Singlomics Biopharmaceuticals, a clinical-stage biotechnology company focused on antibody therapeutics, announced that the first...
Oncolytics Advances Pelareorep Toward Anal Cancer Approval
San Diego, California, USA, April 6, 2026 FDA Engagement Signals Registrational Pathway Progress In a key development for oncolytic...
Adagene & Incyte Drive New MSS CRC Immunotherapy Study
San Diego, USA & Suzhou, China, April 2, 2026 Breakthrough Collaboration in Immuno-Oncology In a significant step forward for...
MiNK Therapeutics Highlights Phase II iNKT Therapy at AACR
NEW YORK, April 3, 2026 MiNK Therapeutics announced that new Phase II clinical trial data for its investigational iNKT...
Advertisements
Agenus Showcases Phase II Cancer Immunotherapy Data at AACR
LEXINGTON, Mass., April 3, 2026 Agenus Inc. has announced that new data from its Phase II clinical study evaluating...
AvenCell Therapeutics Advances Next-Gen CAR-T Therapy
CAMBRIDGE, Mass., April 2, 2026 AvenCell Therapeutics, Inc. has achieved a major regulatory milestone with both the U.S. FDA...
AstraZeneca Reports Imfinzi Combo Success in Liver Cancer
CAMBRIDGE, UK, April 2, 2026 AstraZeneca has announced positive results from the Phase III EMERALD-3 trial, where a combination...
Merck Wins EU Approval for KEYTRUDA Combo in Ovarian Cancer
RAHWAY, N.J., April 2, 2026 Merck (MSD) has secured a major regulatory milestone as the European Commission approves KEYTRUDA®...
Anixa Advances Breast Cancer Vaccine to Phase 2 Trial
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
Advertisement
